TCIM
RGNX icon

TIAA CREF Investment Management’s Regenxbio RGNX Stock Holding History

TIAA CREF Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6.74M Sell
117,527
-283
-0.2% -$14K ﹤0.01% 1266
2018
Q4 		$4.94M Sell
117,810
-2,322
-2% -$136K ﹤0.01% 1386
2018
Q3 		$9.07M Sell
120,132
-84,255
-41% -$6.07M 0.01% 1163
2018
Q2 		$14.7M Buy
204,387
+120,448
+143% +$5.75M 0.01% 915
2018
Q1 		$2.51M Buy
83,939
+16,536
+25% +$481K ﹤0.01% 1993
2017
Q4 		$2.24M Sell
67,403
-2,537
-4% -$76.4K ﹤0.01% 2075
2017
Q3 		$2.31M Sell
69,940
-4,235
-6% -$95.3K ﹤0.01% 2082
2017
Q2 		$1.47M Buy
74,175
+18,647
+34% +$361K ﹤0.01% 2362
2017
Q1 		$1.07M Sell
55,528
-4,125
-7% -$79.6K ﹤0.01% 2478
2016
Q4 		$1.11M Sell
59,653
-403
-0.7% -$7.7K ﹤0.01% 2473
2016
Q3 		$841K Buy
60,056
+197
+0.3% +$2.17K ﹤0.01% 2624
2016
Q2 		$479K Buy
59,859
+44,675
+294% +$496K ﹤0.01% 2877
2016
Q1 		$164K Hold
15,184
– – ﹤0.01% 3007
2015
Q4 		$252K Buy
+15,184
New +$301K ﹤0.01% 3042

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TIAA CREF Investment Management's RGNX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Regenxbio (RGNX) stake by 0.24% in Q1 2019, selling an estimated $14K and leaving 117,527 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

TIAA CREF Investment Management first reported a position in RGNX in Q4 2015 and has held it in 14 quarters since. The position peaked at $14.7M in Q2 2018. 211 funds tracked by Wall St. Rank hold RGNX as of Q1 2019.

  • TIAA CREF Investment Management held 117,527 shares of Regenxbio worth $6.74M as of Q1 2019.
  • TIAA CREF Investment Management sold 283 Regenxbio shares in Q1 2019, an estimated $14K.
  • Regenxbio made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1266 holding.
  • TIAA CREF Investment Management first reported a position in Regenxbio in Q4 2015 and has held it in 14 quarters since.
  • TIAA CREF Investment Management's Regenxbio position peaked at $14.7M in Q2 2018.
  • 211 funds tracked by Wall St. Rank held Regenxbio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.